Multi-Year Supply Agreement Signed with Top-5 European Pharma

Hyxtide has entered a multi-year exclusive supply agreement for three oncology peptide APIs with a leading European pharmaceutical company, valued at over $45M. The agreement covers GMP-grade supply of three proprietary peptide APIs for Phase III clinical trials and commercial launch.